Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy

被引：4

作者：

Delger, A. B. ^{[1
]}

Avakyan, G. N. ^{[1
]}

Oleinikova, O. M. ^{[1
]}

Bogomazova, M. A. ^{[1
]}

Chromych, E. A. ^{[1
]}

Lagutin, Iu. V. ^{[1
]}

机构：

[1] NI Pirogov Russian Natl Med Univ, Minist Hlth & Social Dev Russian Federat, Dept Neurol & Neurosurg, Moscow, Russia

来源：

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2012年 / 153卷 / 05期

关键词：

tenoten; epilepsy; anxiety and depression disorders; ultralow antibody doses; S-100; protein;

D O I：

10.1007/s10517-012-1804-7

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

100103 [病原生物学]; 100218 [急诊医学];

摘要：

The efficiency and safety of tenoten for anxiety and depression disorders in epileptics has been demonstrated. The drug does not change the incidence and severity of epileptic episodes, does not deteriorate the course of the underlying disease, and can be well combined with anticonvulsants. The results indicate the effi ciency of tenoten used to arrest the anxio-depressive disorders in epilepsy.

引用

页码：704 / 706

页数：3

共 8 条

[1]

Avakyan G. N., 2005, ATMOSFERA, P4

[2]

Baran Brigitta, 2002, Ideggyogy Sz, V55, P303

[3]

EPSTEIN OI, 2005, PHARM ULTRALOW DOSE

[4]

Depression and anxiety in epilepsy [J].